Results 131 to 140 of about 15,879 (168)

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]

BMC Cancer
Wenzel M, Filzmayer M, Siech C, Le QC, Lauer B, Theissen L, Hoeh B, Heinzer H, Graefen M, Steuber T, Kriegmair M, Chun FK, Mandel P.   +12 more
europepmc   +1 more source

Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities. [PDF]

Br J Cancer
Waldron NR, Silva D, Westaby D, Jiménez-Vacas J, Taylor J, Sharp A.   +5 more
europepmc   +1 more source

Genomic landscape and precision therapy in prostate cancer: current status and future directions. [PDF]

NPJ Precis Oncol
Ligon JA, Anand S, Singh S, Siddiqui JA, Henegan JC, Singh AP.   +5 more
europepmc   +1 more source

TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR. [PDF]

Front Immunol
Li S, Chen A, Guo C, Gu C, Tang Z, Shen S, Yang D, Mi Y.   +7 more
europepmc   +1 more source

Quantifying the Renal Impact of [¹⁷⁷Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry. [PDF]

J Nucl Med
Büttner T, Hoffmann C, Essler M, Gärtner F, Kreppel B, Küppers J, Ritter M, Fritzsche L, Marinova M, Krausewitz P.   +9 more
europepmc   +1 more source

Comparative Digital Estrogen Receptor Alpha (ERα) Expression Analysis in Benign and Malignant Prostate Tissue of Men and Dogs. [PDF]

Prostate
Lothion-Roy J, Aeschlimann L, Hiller LA, Rottenberg S, Mongan NP, Rutland CS, Rakha E, Dean A, Rubin MA, de Brot S.   +9 more
europepmc   +1 more source

Metastasis of Castration-Resistant Prostate Adenocarcinoma to the Lacrimal Gland: A Case Report. [PDF]

Reports (MDPI)
Milic N, Lojanica MV, Ivanovic M, Matijasevic M, Ivanovic S.   +4 more
europepmc   +1 more source

USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer. [PDF]

Cell Death Dis
Wang Z, Liu X, Li Z, Yuan R, Zheng F, Xiong S, Zeng J, Pang W, Fu B, Li S, Xu S, Deng J.   +11 more
europepmc   +1 more source

Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients. [PDF]

J Cutan Pathol
Sina N, Muhaj F, Lenskaya V, Ivan D, Prieto VG, Curry JL.   +5 more
europepmc   +1 more source

Evaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis. [PDF]

Jpn J Clin Oncol
Hata S, Suzuki S, Fujinami H, Yamanaka N, Shin T.   +4 more
europepmc   +1 more source